Qiagen (QGEN) News Today

Edgestream Partners L.P. bought a new stake in Qiagen (NYSE:QGEN - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 34,704 shares of the company's stock, valued at approximately $1,492,000. Other institutional

US Bancorp DE increased its holdings in shares of Qiagen (NYSE:QGEN - Free Report) by 124.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,529 shares of the company's stock after purchasing an additio

Qsemble Capital Management LP purchased a new position in shares of Qiagen (NYSE:QGEN - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 15,618 shares of the company'

Sei Investments Co. boosted its position in shares of Qiagen (NYSE:QGEN - Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,417,389 shares of the company's stock after acquiring an additional 220,913 s

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.

Susquehanna Fundamental Investments LLC acquired a new position in Qiagen (NYSE:QGEN - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 23,118 shares of the company's

Susquehanna International Securities Ltd. acquired a new position in Qiagen (NYSE:QGEN - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 133,311 shares of the company's stock, valued at approximately $5,731,000. Qiag

Duality Advisers LP decreased its stake in Qiagen (NYSE:QGEN - Free Report) by 62.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,271 shares of the company's stock after selling 34,764 shares during the

Mediolanum International Funds Ltd acquired a new stake in Qiagen (NYSE:QGEN - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 24,683 shares of the company's stock, valued at approximately $974,000. Other hed

Jennison Associates LLC raised its holdings in Qiagen (NYSE:QGEN - Free Report) by 5.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,374,507 shares of the company's stock after purchasing an additional 66,203 shares during the qu

Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Qiagen (NYSE:QGEN - Free Report) by 97.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 263,016 shares of the company's stock after acquiring

BNP Paribas Financial Markets increased its holdings in Qiagen (NYSE:QGEN - Free Report) by 14.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,756,271 shares of the company's stock

Allspring Global Investments Holdings LLC raised its holdings in Qiagen (NYSE:QGEN - Free Report) by 25.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,689,763 shares of the company's stock after

Vanguard Group Inc. grew its stake in shares of Qiagen (NYSE:QGEN - Free Report) by 1.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,815,467 shares of the company's stock after acquiring an additional 83

Wolfe Research raised Qiagen from a "peer perform" rating to an "outperform" rating and set a $50.00 price objective for the company in a research note on Thursday.

Qiagen (NYSE:QGEN - Free Report) - Zacks Research decreased their Q1 2025 EPS estimates for shares of Qiagen in a report issued on Monday, June 17th. Zacks Research analyst M. Mondal now expects that the company will post earnings of $0.47 per share for the quarter, down from their prior estimate

JPMorgan Chase & Co. raised their price objective on Qiagen from $52.00 to $54.00 and gave the stock an "overweight" rating in a research note on Tuesday.

Wellington Management Group LLP boosted its position in shares of Qiagen (NYSE:QGEN - Free Report) by 20.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,271,828 shares of the company's stock after purchas

Qiagen (NYSE:QGEN - Get Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 2,590,000 shares, a decline of 15.6% from the May 15th total of 3,070,000 shares. Based on an average daily volume of 1,010,000 shares, the short-interest ratio is currently 2.6 days. Currently, 1.2% of the shares of the company are short sold.

FIL Ltd grew its stake in shares of Qiagen (NYSE:QGEN - Free Report) by 8.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,099,140 shares of the company's stock after purchasing an additional 399,965 shares during the period. FIL L

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its position in Qiagen (NYSE:QGEN - Free Report) by 0.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,481,873 shares of the company's stock

Parkman Healthcare Partners LLC acquired a new stake in Qiagen (NYSE:QGEN - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 250,000 shares of the company's stock, valued at approximately $10,858,000. Qiagen makes up about 1.5% of Parkma

Point72 Asset Management L.P. decreased its stake in Qiagen (NYSE:QGEN - Free Report) by 66.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,482,769 shares of the company's stock after selling 2,895,950 shares during the quarter. Point7

Point72 Europe London LLP increased its holdings in Qiagen (NYSE:QGEN - Free Report) by 10.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 518,641 shares of the company's stock after buying an add

First Trust Advisors LP lifted its stake in shares of Qiagen (NYSE:QGEN - Free Report) by 11.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,383,766 shares of the company's stock after acquiring an additional

Qiagen (NYSE:QGEN) updated its second quarter 2024 earnings guidance. The company provided EPS guidance of 0.520-0.520 for the period, compared to the consensus estimate of 0.520. The company also issued revenue guidance of $495.0 millionillion-, compared to the consensus estimate of $495.4 millionillion.

Qiagen (NYSE:QGEN) updated its second quarter earnings guidance. The company provided EPS guidance of $0.52 for the period, compared to the consensus estimate of $0.51. The company also issued revenue guidance of $495 millionillion, compared to the consensus estimate of $496.06 millionillion.

Optiver Holding B.V. raised its position in Qiagen (NYSE:QGEN - Free Report) by 1,211.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 47,212 shares of the company's stock after buying an additional 43,61

Allianz Asset Management GmbH lowered its position in shares of Qiagen (NYSE:QGEN - Free Report) by 6.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 267,037 shares of the company's stock after selling 19,440 s

UBS Group AG boosted its stake in Qiagen (NYSE:QGEN - Free Report) by 1,423.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 323,625 shares of the company's stock after purchasing an additional 302,387 shares

Edmond DE Rothschild Holding S.A. lifted its position in Qiagen (NYSE:QGEN - Free Report) by 4.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 677,026 shares of the company's stock aft

Panagora Asset Management Inc. cut its stake in Qiagen (NYSE:QGEN - Free Report) by 63.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,293 shares of the company's stock after selling 38,355 shares during the quarte

Assenagon Asset Management S.A. decreased its holdings in Qiagen (NYSE:QGEN - Free Report) by 98.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,390 shares of the company's stock after selling 793,953

Qiagen (NYSE:QGEN) Shares Down 3.7%

Qiagen (NYSE:QGEN - Free Report) - Research analysts at Zacks Research upped their Q2 2024 EPS estimates for shares of Qiagen in a report issued on Monday, May 20th. Zacks Research analyst M. Mondal now forecasts that the company will post earnings of $0.52 per share for the quarter, up from thei

Qiagen (NYSE:QGEN - Free Report) - Analysts at Zacks Research reduced their Q1 2025 earnings estimates for shares of Qiagen in a research note issued to investors on Monday, May 20th. Zacks Research analyst M. Mondal now forecasts that the company will post earnings per share of $0.48 for the qua